Literature DB >> 4125248

Studies on the developmental cycle of Chlamydia trachomatis: isolation and characterization of the initial bodies.

B Gutter, Y Asher, Y Cohen, Y Becker.   

Abstract

The initial bodies which develop in the inclusion bodies of trachoma agent (Chlamydia trachomatis) were separated from the infected cells nuclei and cytoplasmic components by zone centrifugation in sucrose gradients. The initial bodies are the site of the agent's ribonucleic acid synthesis and serve as precursors to the elementary bodies. The conversion of the initial bodies to elementary bodies is through a process which resembles binary fission. The effects of antibiotics on the development of the trachoma agent initial bodies revealed that rifampin prevented and hydroxyurea affected the formation of the initial bodies. Penicillin led to the formation of structures larger than the initial bodies.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4125248      PMCID: PMC246301          DOI: 10.1128/jb.115.2.691-702.1973

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  RNA SYNTHESIS IN CELLS INFECTED WITH THE MENINGOPNEUMONITIS AGENT.

Authors:  A TAMURA; M IWANAGA
Journal:  J Mol Biol       Date:  1965-01       Impact factor: 5.469

2.  Correlation between morphological and biochemical changes and the appearance of infectivity in FL cell cultures infected with trachoma agent.

Authors:  H BERNKOPF; P MASHIAH; Y BECKER
Journal:  Ann N Y Acad Sci       Date:  1962-03-05       Impact factor: 5.691

3.  Growth characteristics of inclusion blennorrhea virus in cell cultures.

Authors:  L H COLLIER
Journal:  Ann N Y Acad Sci       Date:  1962-03-05       Impact factor: 5.691

4.  Inhibitors of protein biosynthesis. V. Effects of emetine on protein and nucleic acid biosynthesis in HeLa cells.

Authors:  A P Grollman
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

5.  Interaction of trachoma elementary bodies with host cells.

Authors:  Y Becker; E Hochberg; Z Zakay-Rones
Journal:  Isr J Med Sci       Date:  1969 Jan-Feb

Review 6.  The mode of reproduction of psittacosis-lymphogranuloma-trachoma (PLT) group viruses.

Authors:  N Higashi
Journal:  Int Rev Exp Pathol       Date:  1964

7.  Electrophoretic separation of viral nucleic acids on polyacrylamide gels.

Authors:  D H Bishop; J R Claybrook; S Spiegelman
Journal:  J Mol Biol       Date:  1967-06-28       Impact factor: 5.469

8.  Synthesis of trachoma agent proteins in emetine-treated cells.

Authors:  Y Becker; Y Asher
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

9.  Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia.

Authors:  M J Kramer; F B Gordon
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

10.  Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development.

Authors:  R R Friis
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

View more
  5 in total

Review 1.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

Review 2.  The chlamydia: molecular biology of procaryotic obligate parasites of eucaryocytes.

Authors:  Y Becker
Journal:  Microbiol Rev       Date:  1978-06

3.  Cyclic AMP inhibits developmental regulation of Chlamydia trachomatis.

Authors:  R Kaul; W M Wenman
Journal:  J Bacteriol       Date:  1986-11       Impact factor: 3.490

4.  Studies on the developmental cycle of Chlamydia trachomatis: selective inhibition by hydroxyurea.

Authors:  H S Rosenkranz; B Gutter; Y Becker
Journal:  J Bacteriol       Date:  1973-08       Impact factor: 3.490

5.  Penicillin-binding proteins regulate multiple steps in the polarized cell division process of Chlamydia.

Authors:  John V Cox; Yasser Mohamed Abdelrahman; Scot P Ouellette
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.